Literature DB >> 9006936

Identification of the region in actin-binding protein that binds to the cytoplasmic domain of glycoprotein IBalpha.

S C Meyer1, S Zuerbig, C C Cunningham, J H Hartwig, T Bissell, K Gardner, J E Fox.   

Abstract

Actin-binding protein (ABP-280) is a component of the submembranous cytoskeleton and interacts with the glycoprotein (GP) Ibalpha subunit of the GP Ib-IX complex in platelets. In the present studies, we have identified the binding site for GP Ibalpha in ABP-280. A melanoma cell line lacking ABP-280 was stably transfected with the cDNAs coding for GP Ib-IX, then transiently transfected with cDNA coding for various carboxyl-truncates of ABP-280. Immunocapture assays and co-immunoprecipitation experiments from detergent-lysed cells showed that deletion of the carboxyl-terminal repeats 20-24 of ABP-280 had no effect on GP Ib-IX binding, but deletion of residues 2099 through 2136 within repeat 19 abolished binding. In the yeast two-hybrid system, an ABP-280 fragment comprising repeats 17-19 bound GP Ibalpha. Deletion from either end abolished binding. Individual or multiple repeats of ABP-280 were expressed as fusion protein in bacteria and purified; structural folding was evaluated, and binding to GP Ib-IX was assessed. Binding depended on the presence of repeats 17-19. None of the individual repeats were able to bind to GP Ib-IX. These findings demonstrate that residues 1850-2136 comprising repeats 17-19 contain the binding site for GP Ib-IX.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006936     DOI: 10.1074/jbc.272.5.2914

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Periventricular heterotopia and the genetics of neuronal migration in the cerebral cortex.

Authors:  J W Fox; C A Walsh
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton.

Authors:  M Stahlhut; B van Deurs
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

3.  Binding of filamin isoforms to myofibrils.

Authors:  W Chiang; M L Greaser
Journal:  J Muscle Res Cell Motil       Date:  2000-05       Impact factor: 2.698

4.  Localization and enhanced current density of the Kv4.2 potassium channel by interaction with the actin-binding protein filamin.

Authors:  K Petrecca; D M Miller; A Shrier
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

Review 5.  Genetic abnormalities of Bernard-Soulier syndrome.

Authors:  Shinji Kunishima; Tadashi Kamiya; Hidehiko Saito
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

6.  GPIbα regulates platelet size by controlling the subcellular localization of filamin.

Authors:  Taisuke Kanaji; Jerry Ware; Takashi Okamura; Peter J Newman
Journal:  Blood       Date:  2011-12-15       Impact factor: 22.113

7.  The small GTPase RalA targets filamin to induce filopodia.

Authors:  Y Ohta; N Suzuki; S Nakamura; J H Hartwig; T P Stossel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 8.  Heptaspanning membrane receptors and cytoskeletal/scaffolding proteins: focus on adenosine, dopamine, and metabotropic glutamate receptor function.

Authors:  Francisco Ciruela; Laia Canela; Javier Burgueño; Ana Soriguera; Nuria Cabello; Enric I Canela; Vicent Casadó; Antonio Cortés; Josefa Mallol; Amina S Woods; Sergi Ferré; Carmen Lluis; Rafael Franco
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

9.  Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A.

Authors:  R Lin; K Karpa; N Kabbani; P Goldman-Rakic; R Levenson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

10.  Identification of a unique filamin A binding region within the cytoplasmic domain of glycoprotein Ibalpha.

Authors:  Susan L Cranmer; Inna Pikovski; Pierre Mangin; Philip E Thompson; Teresa Domagala; Mark Frazzetto; Hatem H Salem; Shaun P Jackson
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.